Abstract
Background:It is unclear as to which SLE patients respond favorably to belimumab (BEL), and the impact of such treatment on peripheral blood immunophenotype in this population remains unknown.Objectives:This study aimed...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have